Will physician-level measures of clinical performance be used in medical malpractice litigation?

被引：12

作者：

Kesselheim, AS

Ferris, TG

Studdert, DM

机构：

[1] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, Dept Med,Brigham & Womens Hosp, Boston, MA 02115 USA

[3] Massachusetts Gen Hosp, Partners MGH Inst Hlth Policy, Div Gen Med, Boston, MA 02114 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2006年 / 295卷 / 15期

关键词：

D O I：

10.1001/jama.295.15.1831

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1831 / 1834

页数：4

共 24 条

[1]

Bowie Gavin M., 2002, S CAROLINA LAW REV, V54, P495

[2]

*CMS, 2004, CMS DOCT OFF QUAL PR

[3]

*CMS PHYS FOC QUAL, 2005, CHRON DIS PREV MEAS

[4]

COBLE Y, 2004, COMM FUND QUAL IMPR

[5]

Committee on quality of health care in America-Institute of Medicine, 2001, CROSS QUAL CHASM NEW

[6]

Donohue Sharon King, 2002, Ann Health Law, V11, P147

[7]

GASH J, 2004, UTAH LAW REV, P1191

[8]

Hibbard Judith, 2004, Jt Comm J Qual Saf, V30, P347

[9]

*I MED, 2006, COMM RED HLTH INS PE

[10]

IMWINKELRIED EJ, 2003, UNCHARGED MISCONDUCT, V2, P4